Ginsenoside Rg1
Cat. No.：YN380217
CAS No. ：22427-39-0
| 产品名称: | Ginsenoside Rg1 |
| CAS No.: | 22427-39-0 |
| Chemical Name: | 3β,12β-dihydroxydammar-24-ene-6α,20-diyl bis-β-D-glucopyranoside |
| Synonyms: | 人参皂苷 Rg1; Panaxoside A; Panaxoside Rg1 |
| 分子量: | 801.01 |
| 分子式: | C₄₂H₇₂O₁₄ |
| SMILES: | [H][C@]12C(C)(C)[C@@H](O)CC[C@]1(C)[C@]3([H])[C@@]([C@@](CC[C@]4([H])[C@@](CC/C=C(C)/C)(C)O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)(C)[C@]4([H])[C@H](O)C3)(C)C[C@@H]2O[C@]6([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Ginsenoside Rg1 是人参的主要活性成分之一。Ginsenoside Rg1 通过降低大脑Aβ水平来发挥作用。Ginsenoside Rg1 减少NF-κB核易位。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Gao, Y., Li, J., Chu, S., et al.Ginsenoside Rg1 protects mice against streptozotocin-induced type 1 diabetic by modulating the NLRP3 and Keap1/Nrf2/HO-1 pathwaysEur. J. Pharmacol.866,172801(2020)
Zhang, Z., Song, Z., Shen, F., et al.Ginsenoside Rg1 prevents PTSD-like behaviors in mice through promoting synaptic proteins, reducing Kir4.1 and TNF-α in the hippocampusMol. Neurobiol.58(4),1550-1563(2021)
Yang, C., He, X., Zhao, J., et al.Hepatoprotection by Ginsenoside Rg1 in alcoholic liver diseaseInt. Immunopharmacol.92,107327(2021)
Guo, Y., Wang, L., Lu, J., et al.Ginsenoside Rg1 improves cognitive capability and affects the microbiota of large intestine of tree shrew model for Alzheimer's diseaseMol. Med. Rep.23(4),291(2021)
